Kemper Corp

Insider Buying Week 05-10-24 The Earnings Blackout Curtain is Lifting

by

The blog is a work in progress, like a public journal/filing system. Most of the quarterly earnings are behind us, and it is heartening to see that insider buying has picked up a little. Could there be some value in a market that feels scoured over, like an 80% off sale at Neiman Marcus? There were even some large insider buys in marquis names. Could there be some gems here?  This is my first crack at most of them. The Earnings Blackout Curtain is Lifting. You can be an insider, too– by clicking here   Name: Lester B Knight Position: … Read more

Insider Buying Week 12-01-23 AI will Improve everything but the Tesla pickup truck

by

FOMO  (fear of missing out in a year when the S&P is up over 20%) is in full swing. One thing not making the headlines is the market is essentially where it was two years ago, with investors on a roller coaster ride.  AI will improve everything except the Tesla pickup, and gasoline is the cheapest at the pump in years, even as the world seems to be throwing in the towel on preventing climate change. All that ESG and green talk seems to be more expensive than anyone wants to pay for. The magnificent seven took the week off … Read more

Insider Buying Week 11-24-23 Are Investors the Turkey this Thanksgiving?

by

Trying to read the tea leaves and glean some information from insider buying patterns is seldom obvious.  Directors are generally required to own a percentage of their board compensation in the company’s equity.  Generally is the right word because this is not a requirement at every company.  Investors viewing this information have to weigh it against past purchases, if any, actual board stock ownership requirements, the relative size of the purchase, and, of course, the recent price history.  Are they buying near the highs or, more typically, purchasing shares at recent lows in price? Insiders tend to be value buyers, … Read more

Insider Buying Week 8-12-22 Full on Stampede to Buy Stocks

by

The S&P 500  has been on a tear.  It tacked on another 3% on top of last week’s, 4% gain. There was almost nothing that went down. Last Friday it was hard to find something that was not green on your screen. Check out Finviz’s Map of the Market below. It was a full-on stampede to buy stocks. Apple is approaching its all-time high. The money on the sidelines is pouring in. Slightly better CPI prints were the trigger, but inflation is not so easily tamed. For starters, don’t expect much help from lower energy prices. I just attended Denver … Read more

Insider Buying Picks Up Dramatically Week 8-06-21

by

For trade, details click on this link to the trades.  Name Sachs Bruce I Position: Director Shares Bought: 15,000 Average Price Paid: $197.91, Cost: $2,968,650 Company: Vertex Pharmaceuticals Inc. (VRTX) Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease – and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has … Read more